Cardiac Rehabilitation to Improve Breast Cancer Outcomes

Inclusion Criteria:

Breast cancer diagnosis stage I-III
Within 12-months of treatment completion (defined as completion of all oncologic treatments expect endocrine therapy)
Age 18 years or older
At increased risk for cardiovascular disease based on one of the following; a.Treatment with either anthracycline-based or anti-HER2 therapy-based treatment regimen plus the presence of: >2 cardiovascular heart disease risk factors (smoking, hypertension, diabetes mellitus, obesity, dyslipidemia), OR Age (>60 years) at cancer treatment, OR Left ventricular ejection fraction <50%as determined with a clinically ordered echo scan within 6 months of enrollment, b.Treatment with anthracycline followed by trastuzumab
Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

Planned surgery during the study period.
Under cardiology care for known high-risk cardiovascular disease defined as the presence of any of the following: severe, unrevascularized coronary artery disease, severe valvular heart disease, advanced heart failure with a left ventricular ejection fraction <35%)
Metastatic cancer
Unable to exercise (e.g., inability to complete a modified stress test or musculoskeletal condition that prevents adequate participation in exercise)
Adults unable to give consent, pregnant or lactating women, and prisoners are excluded from this study.